Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity. Blood. 2014 Jan 02; 123(1):15-25.
View in:
PubMed
subject areas
Animals
CD8-Positive T-Lymphocytes
Cell Line, Tumor
CpG Islands
Gene Expression Regulation, Leukemic
Gene Silencing
Immune Tolerance
Interferon-gamma
Leukemia
Mice
Mice, Inbred C57BL
Mice, Inbred NOD
Mice, Knockout
Mice, SCID
Mice, Transgenic
RNA, Small Interfering
STAT3 Transcription Factor
Toll-Like Receptor 9
authors with profiles
Justin P. Kline